Please login to the form below

Not currently logged in
Email:
Password:

CAD106

This page shows the latest CAD106 news and features for those working in and with pharma, biotech and healthcare.

AZ gets $100m from Lilly as Alzheimer's drug progresses

AZ gets $100m from Lilly as Alzheimer's drug progresses

Meanwhile, Novartis and Amgen are co-developing a BACE inhibitor called CNP520 in combination with investigational immunotherapy CAD106 in people at risk of developing AD dementia, recently starting a phase

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics